Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models

Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models have?

Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models has 36 citations in the OpenAlex counts ScholarIQ stores.

When was Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models published?

Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models has 2014 year in the ScholarIQ index.

What is the open-access status of Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models?

Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models has green oa status in the ScholarIQ index.

What is the DOI of Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models?

The DOI for Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models is on the source record.

What is the PMID of Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models?

The PMID for Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models is on the source record.

What is the OpenAlex record for Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models?

The OpenAlex for Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models is on the source record.